Cardea Bio

Cardea Bio Inc. has pioneered the creation of a Tech + Bio infrastructure, offering chipsets based on proprietary biologically gated transistors, known as Cardean Transistors™, which directly connect biology to computers. These transistors utilize graphene, a nanomaterial that is biocompatible and, due to being only one atom thick, exhibits near-perfect conductivity, unlike conventional semiconductor materials like silicon. This innovation replaces optical observation with interactive real-time streams of multi-omics signal analysis, representing a new paradigm in life science observation where multi-omics data streams will become the new standard, moving beyond the predominantly single-method technologies currently in use. Collaborating with innovative partners, Cardea Bio can directly link biology to computational power, transforming real-time biological signals into digital information. This enables immediate biological insights and connects a new generation of applications to life.